EVO:NSD-Evotec SE ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 5.02

Change

-0.08 (-1.57)%

Market Cap

USD 2.51B

Volume

0.87M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
NBIX Neurocrine Biosciences Inc

+0.64 (+0.46%)

USD 13.68B
VTRS Viatris Inc

-0.59 (-5.00%)

USD 13.36B
ITCI Intracellular Th

-1.44 (-2.15%)

USD 7.72B
LNTH Lantheus Holdings Inc

+1.39 (+1.87%)

USD 4.49B
ALKS Alkermes Plc

+0.16 (+0.66%)

USD 4.11B
ALVO Alvotech

+0.06 (+0.44%)

USD 3.79B
HCM HUTCHMED DRC

+1.35 (+6.93%)

USD 3.23B
AVDL Avadel Pharmaceuticals PLC

-0.42 (-2.58%)

USD 2.99B
INDV Indivior PLC Ordinary Shares

+0.09 (+0.51%)

USD 2.93B
AMPH Amphastar P

+0.22 (+0.52%)

USD 2.06B

ETFs Containing EVO

ODDS Pacer BlueStar Digital En.. 7.75 % 0.00 %

+0.27 (+0.00%)

USD 0.81M
BETS:XETRA 6.59 % 0.00 %

N/A

N/A
XSDX:SW Xtrackers ShortDAX Daily .. 3.88 % 0.00 %

N/A

USD 0.21B
EWD iShares MSCI Sweden ETF 3.87 % 0.53 %

+0.48 (+0.00%)

USD 0.36B
OMXS:LSE iShares OMX Stockholm Cap.. 3.20 % 0.00 %

+3.50 (+0.00%)

USD 3.01B
XWD1:LSE Xtrackers MSCI World Swap.. 2.65 % 0.00 %

+0.09 (+0.00%)

USD 1.24B
BJK VanEck Gaming ETF 0.00 % 0.66 %

+0.21 (+0.00%)

USD 0.04B
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
XSDX:LSE Xtrackers ShortDAX Daily .. 0.00 % 0.00 %

-9.00 (0.00%)

USD 0.21B
XSPU:LSE Xtrackers - S&P 500 Swap .. 0.00 % 0.00 %

+0.48 (+0.00%)

USD 4.97B
XSPX:LSE Xtrackers S&P 500 Swap UC.. 0.00 % 0.00 %

+22.50 (+0.00%)

USD 4.97B
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

-2.20 (0.00%)

USD 0.05B
DXSN:F Xtrackers - ShortDAX Dail.. 0.00 % 0.00 %

-0.12 (0.00%)

USD 0.21B
DXSP:F Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

-0.04 (0.00%)

USD 0.05B
EL4C:F Deka STOXX Europe Strong .. 0.00 % 0.00 %

+0.06 (+0.00%)

USD 0.28B
EXV9:F iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

USD 0.09B
XDN0:F db x-trackers MSCI Nordic.. 0.00 % 0.00 %

+0.27 (+0.00%)

USD 1.03B
DXSP:XETRA Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

-0.04 (0.00%)

USD 0.05B
EL4C:XETRA Deka STOXX Europe Strong .. 0.00 % 0.00 %

+0.30 (+0.00%)

USD 0.29B
DXSN:XETRA Xtrackers - ShortDAX Dail.. 0.00 % 0.00 %

-0.12 (0.00%)

USD 0.21B
EXV9:XETRA iShares (DE) I - iShares .. 0.00 % 0.00 %

-0.17 (0.00%)

USD 0.10B
OM3X:XETRA iShares OMX Stockholm Cap.. 0.00 % 0.00 %

+0.51 (+0.00%)

USD 1.31B
XDN0:XETRA db x-trackers MSCI Nordic.. 0.00 % 0.00 %

+0.35 (+0.00%)

USD 1.03B
DXW:CA Dynamic Active Internatio.. 0.00 % 0.00 %

+0.14 (+0.00%)

CAD 0.02B
BETZ Roundhill Sports Betting .. 0.00 % 0.00 %

+0.19 (+0.00%)

USD 0.08B
XNZN:XETRA Xtrackers Nordic Net Zero.. 0.00 % 0.00 %

+0.15 (+0.00%)

USD 0.17B
XDN0:SW Xtrackers MSCI Nordic UCI.. 0.00 % 0.00 %

N/A

USD 1.03B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -57.20% 14% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.20% 14% F 6% D-
Trailing 12 Months  
Capital Gain -45.67% 39% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.67% 39% F 21% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -9.80% 47% F 27% F
Dividend Return -9.80% 47% F 26% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.87% 91% A- 75% C
Risk Adjusted Return -46.96% 39% F 21% F
Market Capitalization 2.51B 90% A- 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector